Ronald Bailey | July 2, 2009
GenomeWeb News is
reporting the results of a very preliminary study in which
researchers test smokers for a genetic variant that slightly
increases their risk of lung cancer:
Researchers from the National Human Genome Research Institute and elsewhere used online and telephone surveys to gauge smokers' perceptions and understanding of online genetic test results indicating whether individuals carried a copy of the glutathione S-transferase gene GSTM1. Previous research suggests those missing the enzyme have a slightly elevated lung cancer risk...
The researchers evaluated 44 smokers between the ages of 23 and 55 years old. Participants received a mouth swab kit by mail and were notified when the results were available online...
Half of the smokers tested were missing GSTM1. All of these individuals reported that they understood that this was a higher risk condition...
All participants sought some form of help quitting and 91 percent of individuals in both groups requested nicotine replacement therapy. After six months, five individuals in the higher risk group and one in the lower risk group reported that they had quit smoking. Still, the study authors were cautious about linking smoking cessation to the test itself, noting that "the study was not sufficiently powered for, nor was it a study aim to, assess smoking cessation as an outcome."
Of course, some bioethicists think that such direct-to-consumer genetic testing needs to be strictly regulated.
Go here for whole GenomeWeb News report.
Reason needs your support. Please donate today!
Try Reason's award-winning print edition today! Your first issue is FREE if you are not completely satisfied.
Site comments/questions:
Media Inquiries and Reprint Permissions:
(310) 367-6109
Editorial & Production Offices:
3415 S. Sepulveda Blvd.
Suite 400
Los Angeles, CA 90034
(310) 391-2245